目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Neurodiagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Neurodiagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
4.3. Neuroimaging Technologies
4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Computed Tomography (CT)
4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Magnetic Resonance Imaging (MRI)
4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Nuclear Medicine Imaging (PET, SPECT)
4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Near infrared spectroscopic imaging (NIRS)
4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Electro-encephalography (EEG)
4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.7. Magneto-encephalography (MEG)
4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.8. Voxel based morphometry (VBM)
4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. In Vitro Diagnostics
4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Neuroinformatics
4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Neurodiagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Hospitals and Clinics
5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Diagnostic Laboratories
5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Imaging Centers Market
5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis
6.1. Neurodiagnostics Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. UAE
6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. South Africa
6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Canon Medical Systems Corporation
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Siemens Healthineers AG
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Koninklijke Philips N.V.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Thermo Fisher Scientific, Inc.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. FUJIFILM Corporation
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Natus Medical Incorporated (Natus)
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Lifelines Neuro
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Advanced Brain Monitoring, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. NIHON KOHDEN CORPORATION.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. F. Hoffmann-La Roche Ltd
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. GE HealthCare.
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
7.4.12. Mitsar Co. LTD.
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/ Strategic Initiatives